Clinical Trial Update: A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 single-arm study is evaluating EVX-01 in combination with pembrolizumab for adults with unresectable or metastatic melanoma; the trial is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• EVX-01
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Evaxion Biotech A/S | Conditions: Melanoma Stage IV, Unresectable Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING